JPRN-jRCT2080225238已完成3 期
A Multi-centre Long-term Extension Study to Assess the Safety and Efficacy of GSK3196165 in the Treatment of Rheumatoid Arthritis
GlaxoSmithKline K.K.0 个研究点目标入组 2,640 人开始时间: 2020年6月19日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 2,640
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Participants with rheumatoid arthritis who are aged >=18 years at the time of signing informed consent, who have completed one of the qualifying GSK3196165 clinical studies and who, in the opinion of the investigator, may benefit from treatment with GSK3196165.
- •-Body weight >=40 kilograms (kg).
- •Other inclusion criteria specified protocol may also be followed.
排除标准
- •-Had study intervention permanently discontinued at any time during a qualifying study.
- •-Were temporarily discontinued from study intervention at the time of the final study visit of a qualifying study and, in the opinion of the investigator, participation in the extension study poses an unacceptable risk for the participant's participation.
- •Other exclusion criteria specified protocol may also be followed.
研究者
相似试验
进行中（未招募）
不适用
Oral Revatio in Pediatric PAH - Long-term follow-on Study to A1481131.MedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersPulmonary Arterial HypertensionEUCTR2005-000963-25-Outside-EU/EEAPfizer Limited, Ramsgate Road, Sandwich, Kent, UK220
进行中（未招募）
不适用
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil in the Treatment of Subjects Who Have Completed Study A1481131 - N/APulmonary Arterial HypertensionEUCTR2005-000963-25-FIPfizer Limited, Ramsgate Road, Sandwich, Kent, UK185
进行中（未招募）
1 期
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil in the Treatment of Subjects Who Have Completed Study A1481131 - N/APulmonary Arterial HypertensionEUCTR2005-000963-25-GBPfizer Limited, Ramsgate Road, Sandwich, Kent, UK234
进行中（未招募）
1 期
A Multicenter, Long-Term Extension Study to Assess Safety of Oral Sildenafil in the Treatment of Subjects Who Have Completed Study A1481131 - N/AMedDRA version: 8.1Level: LLTClassification code 10064911Pulmonary Arterial HypertensionEUCTR2005-000963-25-SKPfizer Limited, Ramsgate Road, Sandwich, Kent, UK185
进行中（未招募）
不适用
Oral Revatio in Pediatric PAH- Long term follow on study to A1481131Pulmonary Arterial HypertensionMedDRA version: 14.1Level: PTClassification code 10064911Term: Pulmonary arterial hypertensionSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2005-000963-25-SEPfizer Limited, Ramsgate Road, Sandwich, Kent, UK200